Under the agreement, VWR will distribute Axela’s proprietary dotLab system and reagents across North America. This arrangement significantly expands VWR’s instrumentation offerings in the protein research sector. Axela’s field scientists and territory managers will provide additional commercial and technical support for VWR’s sales and marketing efforts.
Brian Kerslake, vice president of life science at VWR, said: “The strategic addition of Axela’s innovative products and technologies to our life science portfolio significantly enhances VWR’s network of suppliers.”